Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

RPRX - Royalty Pharma plc Financial Statements | Finranks

Home

/

RPRX

R

Royalty Pharma plc (RPRX)

NMS – Real Time Price. Currency in USD

59.04

+1.25 (2.17%)

Market open: Aug 12, 2026, 10:11 AM EDT

58.02

+0.23 (0.40%)

Previous after-hours: Aug 11, 2026, 7:43 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

2.38B

2.26B

2.35B

2.24B

Cost of goods sold

-4M

-

-

-6M

Gross Profit

2.37B

-

-

2.23B

Operating expenses (excl. COGS)

-815M

-971M

-862M

-1.31B

Operating Income

1.56B

1.29B

1.49B

923M

Non-operating income, total

-235M

38M

208M

-693M

Pretax income

1.32B

1.33B

1.70B

230M

Equity in earnings

-

-

-

-

Taxes

0

0

0

0

Non-controlling/minority interest

-553M

-472M

-565M

-187M

After tax other income/expense

0

0

0

0

Net income before discontinued operations

771M

859M

1.13B

43M

Discontinued operations

0

0

0

0

Net income

771M

859M

1.13B

43M

Dilution adjustment

235M

277M

393M

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

19.62B+7.7%

18.22B+11.2%

16.38B-2.6%

16.81B

Total current assets

1.53B

1.80B

1.27B

2.55B

Total non-current assets

18.09B

16.42B

15.11B

14.26B

Total liabilities

9.91B+25.7%

7.88B+25.1%

6.30B-13.6%

7.29B

Total current liabilities

636M

1.25B

161M

1.17B

Total non-current liabilities

9.27B

6.63B

6.14B

6.12B

Total equity

9.71B

10.34B

10.08B

9.53B

Total liabilities & shareholders' equities

19.62B

18.22B

16.38B

16.81B

Total debt

8.97B+17.8%

7.61B+24.1%

6.14B-13.8%

7.12B

Name

2025

2024

2023

2022

Cash from operating activities

2.59B

2.79B

3.03B

2.14B

Cash from investing activities

-1.71B

-2.70B

-2.10B

-1.02B

Cash from financing activities

-1.19B

356M

-2.16B

-952M

Free cash flow

2.59B-7.1%

2.79B-7.9%

3.03B+41.4%

2.14B